<DOC>
	<DOCNO>NCT00985985</DOCNO>
	<brief_summary>A multi-center , randomize , double-blind , placebo-controlled , 4-arm clinical study evaluate efficacy safety nicotine lozenge ( 2mg 4mg ) smoking cessation adult cigarette smoker motivate quit smoking . Successful quitter participant smoke occasionally follow week 24 till 12 month .</brief_summary>
	<brief_title>Efficacy Safety Study Nicotine Mint Lozenge ( 2mg 4mg ) Smoking Cessation</brief_title>
	<detailed_description />
	<mesh_term>Nicotine</mesh_term>
	<criteria>Participant must 18 year age old ; Participant motivate smoke cessation use nicotine mint lozenge ; Participant habit smoke regularly every day least 1 year ; Participant able read provide write informed consent . Participant us form tobacco cigarette pipe , cigar , snuff , smokeless tobacco within 30 day entry study ; Participant use nicotine delivery system nicotine gum , nicotine patch , nicotine inhaler , nicotine nasal spray etc . within 30 day study entry ; Participant smoke substance within 30 day study entry ( cannabis , cocaine , heroin , ice drug , herbal cigarette etc ) ; The participant past history alcohol drug abuse ; Participants use smoke cessation aid ( include bupropion , varenicline , traditional Chinese medicine herbal , acupuncture , consultation etc ) , within 30 day study entry . ; Participant currently involve another clinical trial use investigational medication within 30 day study entry ; Any previous participation study ; Participant member household another clinical subject . Subject relative study site staff member study staff ; Participant pregnant breastfeeding , childbearing potential refusing take medical contraception measure ( within first 24 week study ) . ( Note : All female subject childbearing potential must take urine pregnancy test entry study , negative result subject permit study . ) ; Participants heart cerebral vascular disease stable control medication irregular heartbeat heart attack within last 3 month ; Participants poorly control high blood pressure medication , systolic BP great equal 140mmHg , diastolic BP great equal 90mmHg administration ; Participants hyperthyroidism current application insulin diabetes ; Participants myocardial infarction cerebral vascular accident recently ( within past 3 month ) ; Participants unable fulfill study requirement relation conform visit schedule ; Participants allergy Aspartame Phenylpyruvic acid ( edulcorant widely use food drink ) ï¼Œor diagnose Phenylketonuria ; The clinically significant pulmonary , gastrointestinal , liver , neurological , renal haematological abnormality . ( unstable worsen angina pectoris , Prinzmetal 's angina , nerve circulatory problem , rheumatoid arthritis , moderate severe COPD ) ; A medical history , opinion investigator , might jeopardize safety subject validity study result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>smoke cessation</keyword>
	<keyword>nicotine lozenge</keyword>
	<keyword>nicotine replacement therapy</keyword>
</DOC>